DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR FEBUXOSTAT

« Back to Dashboard

All Clinical Trials for Febuxostat

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00102440 ↗	Febuxostat Versus Allopurinol Control Trial in Subjects With Gout	Completed	Takeda	Phase 3	2002-07-01	The purpose of this study is to evaluate the safety and efficacy of febuxostat, once daily (QD), versus allopurinol in subjects with gout.
NCT00174915 ↗	Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.	Completed	Takeda	Phase 3	2003-02-01	The purpose of this study is to compare febuxostat, allopurinol and placebo, once daily (QD), in subjects with gout.
NCT00174941 ↗	Long-Term Safety of Febuxostat in Subjects With Gout.	Completed	Takeda	Phase 2	2001-03-01	The purpose of this study is to evaluate the long-term safety of febuxostat, once daily (QD), in maintaining serum urate levels within clinically acceptable levels in subjects with gout.
NCT00174967 ↗	Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout	Completed	Takeda	Phase 2	2001-01-01	The purpose of this study is to determine the efficacy of febuxostat, once daily (QD), in reducing serum urate levels in subjects with gout.
NCT00175019 ↗	Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010	Completed	Takeda	Phase 3	2003-07-01	The purpose of this study is to determine the long-term safety of febuxostat, once daily (QD), compared to allopurinol in reducing serum urate levels in subjects with gout.
NCT00430248 ↗	Efficacy and Safety of Oral Febuxostat in Participants With Gout	Completed	Takeda	Phase 3	2007-02-01	The purpose of this study is to compare the efficacy and safety of febuxostat, once Daily (QD), to allopurinol in subjects with hyperuricemia and gout.
NCT00821392 ↗	Phase III Trial of Febuxostat in Korea Gout Patients	Completed	SK Chemicals Co.,Ltd.	Phase 3	2006-08-01	This study was designed to evalute the efficacy and safety of Febuxostat after oral administration to patientd with gout in Korea

Clinical Trial Conditions for Febuxostat

Condition Name

Condition Name for Febuxostat
Intervention	Trials
Gout	31
Hyperuricemia	17
Chronic Kidney Disease	4
Hypertension	3

Condition MeSH

Condition MeSH for Febuxostat
Intervention	Trials
Gout	26
Hyperuricemia	24
Renal Insufficiency, Chronic	9
Kidney Diseases	9

Clinical Trial Locations for Febuxostat

Trials by Country

Trials by Country for Febuxostat
Location	Trials
United States	387
Japan	30
Canada	18
Australia	11
Mexico	11

Trials by US State

Trials by US State for Febuxostat
Location	Trials
Texas	19
Florida	16
California	16
North Carolina	14
Georgia	12

Clinical Trial Progress for Febuxostat

Clinical Trial Phase

Clinical Trial Phase for Febuxostat
Clinical Trial Phase	Trials
Phase 4	16
Phase 3	15
Phase 2/Phase 3	1

Clinical Trial Status

Clinical Trial Status for Febuxostat
Clinical Trial Phase	Trials
Completed	39
Not yet recruiting	19
Recruiting	10

Clinical Trial Sponsors for Febuxostat

Sponsor Name

Sponsor Name for Febuxostat
Sponsor	Trials
Takeda	19
Ardea Biosciences, Inc.	6
AstraZeneca	5

Sponsor Type

Sponsor Type for Febuxostat
Sponsor	Trials
Industry	53
Other	48
NIH	1